These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 18665138
1. Leukocytapheresis for the treatment of IBD. Sigurbjörnsson FT, Bjarnason I. Nat Clin Pract Gastroenterol Hepatol; 2008 Sep; 5(9):509-16. PubMed ID: 18665138 [Abstract] [Full Text] [Related]
2. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study. Martín de Carpi J, Vilar P, Prieto G, García Novo MD, Ribes C, Varea V. J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949 [Abstract] [Full Text] [Related]
3. Addition of leukocytapheresis to steroid therapy: is it beneficial in recurrence of moderate-to-severe ulcerative colitis? Jo Y, Matsumoto T, Mibu R, Iida M. Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S3-9. PubMed ID: 14530652 [Abstract] [Full Text] [Related]
4. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Sands BE, Sandborn WJ, Feagan B, Löfberg R, Hibi T, Wang T, Gustofson LM, Wong CJ, Vandervoort MK, Hanauer S, Adacolumn Study Group. Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921 [Abstract] [Full Text] [Related]
5. Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. Domènech E, Hinojosa J, Esteve-Comas M, Gomollón F, Herrera JM, Bastida G, Obrador A, Ruiz R, Saro C, Gassull MA, Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1347-52. PubMed ID: 15606397 [Abstract] [Full Text] [Related]
6. Leukocytapheresis for treatment of IBD. Kohgo Y, Ashida T, Maemoto A, Ayabe T. J Gastroenterol; 2003 Mar; 38 Suppl 15():51-4. PubMed ID: 12698872 [Abstract] [Full Text] [Related]
16. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients. Tanaka T, Okanobu H, Yoshimi S, Murakami E, Kogame A, Imagawa H, Numata Y, Kuga Y, Moriya T, Ohya T, Kajiyama G. Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860 [Abstract] [Full Text] [Related]
18. Leukocytapheresis therapy for steroid-naïve patients with active ulcerative colitis: its clinical efficacy and adverse effects compared with those of conventional steroid therapy. Nishioka C, Aoyama N, Maekawa S, Shirasaka D, Nakahara T, Tamura T, Fukagawa M, Umezu M, Abe T, Kasuga M. J Gastroenterol Hepatol; 2005 Oct; 20(10):1567-71. PubMed ID: 16174075 [Abstract] [Full Text] [Related]
19. Efficacy and safety of granulocyte and monocyte adsorption apheresis for ulcerative colitis: a meta-analysis. Yoshino T, Nakase H, Minami N, Yamada S, Matsuura M, Yazumi S, Chiba T. Dig Liver Dis; 2014 Mar; 46(3):219-26. PubMed ID: 24268950 [Abstract] [Full Text] [Related]